SG/CALL/WALGREENS BOOTS ALLIANCE/27/0.1/17.01.25 Stock

Warrant

DE000SW3M6B8

Delayed Deutsche Boerse AG 02:26:34 2024-07-01 EDT
0.01 EUR 0.00% Intraday chart for SG/CALL/WALGREENS BOOTS ALLIANCE/27/0.1/17.01.25
Current month-75.00%
1 month-64.29%
Date Price Change
24-07-01 0.01 0.00%
24-06-28 0.01 0.00%
24-06-27 0.01 -70.59%
24-06-26 0.034 -2.86%
24-06-25 0.035 -7.89%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 02:26 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying WALGREENS BOOTS ALLIANCE, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SW3M6B
ISINDE000SW3M6B8
Date issued 2023-09-19
Strike 27 $
Maturity 2025-01-17 (201 Days)
Parity 10 : 1
Emission price 0.2
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.41
Lowest since issue 0.009
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 0.4480
Difference Strike 14.9 $
Difference Strike %+55.20%
Intrinsic value 0.000000

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
-
More about the company

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Walgreens Boots Alliance, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
12.1 USD
Average target price
17.08 USD
Spread / Average Target
+41.24%
Consensus